http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001190283-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff2a8efea2afa96a4a0375964c1ef39a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2000-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdab961b6858fd85c6209203ada30a9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37ad7934963646204721987a6e7a68ad |
| publicationDate | 2001-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001190283-A |
| titleOfInvention | Novel mammalian peptides and polynucleotides encoding them |
| abstract | PROBLEM TO BE SOLVED: To provide a novel mammalian peptide, particularly a proto-oncogene H Activity of suppressing canceration of cells by -ras or Hr Provided are a peptide having an activity of suppressing the growth of cells transformed with as, and a polypeptide encoding the same. SOLUTION: Differential display using total RNA extracted from ATDC5 cells, which is a chondrogenic EC cell line, is performed to isolate a polypeptide encoding the following peptide (A) or (B). (A) A peptide having a specific amino acid sequence derived from a mouse or from a human. (B) the amino acid sequence has an amino acid sequence having one or more amino acid substitutions, deletions, insertions, or metastases, and is H-ras cancerous cells or H-ras. A peptide having an activity of inhibiting the growth of cells transformed with ras. |
| priorityDate | 1999-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 529.